![Athena Countouriotis](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Athena Countouriotis
Directeur/Bestuurslid bij
BIOMARIN PHARMACEUTICAL INC.
Vermogen: 1 M $ op 30-06-2026
Profiel
Athena Countouriotis is lid van de raad van bestuur van Iovance Biotherapeutics, Inc., NuMedii, Inc. en Passage Bio, Inc. en President, Chief Executive Officer & Director bij Turning Point Therapeutics, Inc. Dr. Countouriotis was voorheen Director-Oncology Global Clinical Research bij Bristol Myers Squibb Co., Chief Medical Officer & Senior Vice President voor Halozyme Therapeutics, Inc., Chief Medical Officer & Senior Vice President voor Adverum Biotechnologies, Inc., Associate Medical Director bij CTI BioPharma Corp. en Chief Medical Officer van Ambit Biosciences Corp. Dr. Countouriotis behaalde een doctoraat aan de Tufts University School of Medicine en een doctoraat aan de University of California, Los Angeles.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 02-06-2026 | 21.040 ( 0,01% ) | 1 M $ | 30-06-2026 | |
PASSAGE BIO, INC. 0,03% | 19-05-2026 | 945 ( 0,03% ) | 4 612 $ | 30-06-2026 |
| 16-06-2026 | 0 ( -.--% ) | - $ | 30-06-2026 |
Laatste nieuws over Athena Countouriotis
Actieve functies van Athena Countouriotis
| Bedrijven | Functie | Begin |
|---|---|---|
| IOVANCE BIOTHERAPEUTICS, INC. | Directeur/Bestuurslid | 10-06-2019 |
| PASSAGE BIO, INC. | Directeur/Bestuurslid | 01-02-2020 |
| BIOMARIN PHARMACEUTICAL INC. | Directeur/Bestuurslid | 27-12-2023 |
Avenzo Therapeutics, Inc.
 Avenzo Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development for oncology therapies used in treating of cancer | Algemeen Directeur | - |
Capstan Therapeutics, Inc.
 Capstan Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotechnology company that develops targeted in vivo RNA technologies | Voorzitter | 12-10-2022 |
Recludix Pharma, Inc.
 Recludix Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which develops novel small molecule medicines for inflammatory and immune related diseases | Voorzitter | 12-09-2022 |
NuMedii, Inc.
 NuMedii, Inc. Miscellaneous Commercial ServicesCommercial Services Discovers and de-risks effective new drugs by translating Life Sciences Big Data into therapies | Directeur/Bestuurslid | 20-06-2018 |
Leal Therapeutics, Inc.
 Leal Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops neuro-metabolic therapies for CNS disorders | Directeur/Bestuurslid | - |
Eerdere bekende functies van Athena Countouriotis
| Bedrijven | Functie | Einde |
|---|---|---|
| CARDIFF ONCOLOGY, INC. | Directeur/Bestuurslid | 24-01-2020 |
| ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Opleiding van Athena Countouriotis
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
51
Eerstegraads connecties
17
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 17 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
CTI BioPharma Corp.
 CTI BioPharma Corp. Pharmaceuticals: MajorHealth Technology Engages in acquisition, development and commercialization of novel targeted therapies for blood-related cancers | Health Technology |
BioMarin Pharmaceutical, Inc.
 BioMarin Pharmaceutical, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes innovative pharmaceuticals for serious diseases & medical conditions | Health Technology |
Halozyme Therapeutics, Inc.
 Halozyme Therapeutics, Inc. BiotechnologyHealth Technology Engages in the development and commercialization of recombinant human enzymes for the infertility, ophthalmology & oncology markets | Health Technology |
Ambit Biosciences Corp.
 Ambit Biosciences Corp. Pharmaceuticals: MajorHealth Technology Develops and sells molecule kinase inhibitors for the treatment of cancer | Health Technology |
Turning Point Therapeutics, Inc.
 Turning Point Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage structure-based drug design company for discovery and development of precision medicines for cancer and other diseases | Health Technology |
University of California, Los Angeles
 University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cardiff Oncology, Inc.
 Cardiff Oncology, Inc. Medical SpecialtiesHealth Technology Develops diagnostic products | Health Technology |
Iovance Biotherapeutics, Inc.
 Iovance Biotherapeutics, Inc. BiotechnologyHealth Technology Develops biotechnological products for the treatment of cancer | Health Technology |
NuMedii, Inc.
NuMedii, Inc. Miscellaneous Commercial ServicesCommercial Services Discovers and de-risks effective new drugs by translating Life Sciences Big Data into therapies | Commercial Services |
Adverum Biotechnologies, Inc.
 Adverum Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells novel gene therapies | Health Technology |
Tufts University School of Medicine
 Tufts University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Passage Bio, Inc.
 Passage Bio, Inc. BiotechnologyHealth Technology Develops therapies for the treatment of monogenic central nervous system disorders | Health Technology |
Recludix Pharma, Inc.
Recludix Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which develops novel small molecule medicines for inflammatory and immune related diseases | Commercial Services |
Capstan Therapeutics, Inc.
Capstan Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotechnology company that develops targeted in vivo RNA technologies | Commercial Services |
Leal Therapeutics, Inc.
Leal Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops neuro-metabolic therapies for CNS disorders | Health Technology |
Avenzo Therapeutics, Inc.
Avenzo Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development for oncology therapies used in treating of cancer | Health Technology |
